Influenza now killing more Nova Scotians than COVID-19
Nova Scotians are facing a new reality as the latest respiratory watch report reveals that for the first time since the COVID-19 pandemic began, the number of deaths from influenza has surpassed the number of COVID-19 deaths in the province. According to the report, 124 Nova Scotians have succumbed to influenza during the 2024-25 respiratory season, which started on Aug. 25, 2024, and will continue until Aug. 29, 2025. In comparison, there have been 108 deaths attributed to COVID-19 during the same period.
Infectious diseases doctor, Dr. Lisa Barrett, expressed concern over the rising number of deaths from both influenza and COVID-19. She emphasized that while some may view the shift from COVID-19 to influenza as a return to normalcy, the presence of two deadly viruses circulating simultaneously poses a significant threat to public health. This year’s global flu season has been particularly severe, making it one of the worst in the last decade.
Dr. Robert Strang, Nova Scotia’s chief medical officer of health, acknowledged that pandemics eventually transition into endemic phases, leading to a resurgence of other respiratory viruses like influenza and respiratory syncytial virus (RSV). He emphasized the importance of continuing precautionary measures such as hand hygiene, mask-wearing, staying home when sick, and vaccination to mitigate the spread of these viruses.
Despite the critical role of vaccines in preventing severe illness and death, data revealed a concerning trend in vaccination rates. While 29% of the population received flu shots for the current season, only 18% were vaccinated against COVID-19. Strang stressed the effectiveness of vaccines in reducing respiratory virus-related deaths and encouraged the public to prioritize vaccination.
To address the growing threat of respiratory viruses, the province plans to expand eligibility for the RSV vaccine to include individuals aged 75 and above, regardless of their living situation. Previously, only individuals aged 60 and above residing in long-term care facilities or awaiting placement were eligible for the publicly funded vaccine.
As Nova Scotians navigate the evolving landscape of respiratory illnesses, adherence to preventive measures and vaccination efforts will be crucial in safeguarding public health and reducing the impact of influenza and COVID-19 on the community.
